WaferGen Q2 Revenues Increase Five-Fold | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen today reported revenues grew more than 500 percent to $432,000 during the second quarter on the strength of it SmartChip Early-Access Program.

Under the program, WaferGen's SmartChip systems, SmartChips, and/or SmartCHip Gene Expression Profiling Services were sold to some early access customers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.